Frequency of anti-PF4/heparin antibody formation in TKA and THA patients
| . | TKA patients . | THA patients . | ||||||
|---|---|---|---|---|---|---|---|---|
| No anticoagulation . | Fondaparinux . | No anticoagulation . | Fondaparinux . | |||||
| No./Total . | % . | No./Total . | % . | No./Total . | % . | No./Total . | % . | |
| With DMT | 57/370 | 15.4 | 63/296 | 21.3 | 21/232 | 9.1 | 31/214 | 14.5 |
| Without DMT | 13/201 | 6.5 | 2/35 | 5.7 | 6/130 | 4.6 | 0/24 | 0 |
| P = .002 | P = .025 | P = .147 | P = .051 | |||||
| . | TKA patients . | THA patients . | ||||||
|---|---|---|---|---|---|---|---|---|
| No anticoagulation . | Fondaparinux . | No anticoagulation . | Fondaparinux . | |||||
| No./Total . | % . | No./Total . | % . | No./Total . | % . | No./Total . | % . | |
| With DMT | 57/370 | 15.4 | 63/296 | 21.3 | 21/232 | 9.1 | 31/214 | 14.5 |
| Without DMT | 13/201 | 6.5 | 2/35 | 5.7 | 6/130 | 4.6 | 0/24 | 0 |
| P = .002 | P = .025 | P = .147 | P = .051 | |||||